Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michell Manu"'
Autor:
James L Gulley, Ravi Madan, Jennifer Marte, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, Manuk Manukyan, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Kenneth Canubas, Nikki William
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d25a5872f13a4fdb8aacbef6001b8049
Autor:
Ravi Madan, Jennifer Marte, James Gulley, Antonios Papanicolau-Sengos, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, William Dahut, Shania Bailey, Wiem Lassoued, Nikki Williams, Michell Manu, Peter Pinto
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8e79fc4f580a4855a89071a3c3d4dbd5
Autor:
Fatima Karzai, Peter A. Pinto, Antonios Papanicolau-Sengos, Amy Hankin, William L. Dahut, James L. Gulley, Michell Manu, Shania Bailey, Nikki Williams, Houssein Abdul Sater, Ravi A. Madan, Wiem Lassoued, Jennifer L. Marte
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundProstate cancer (PC) is the most common non-cutaneous diagnosed cancer among men in USA.1 Although clinical outcomes are favorable for patients with localized disease, 20–30% of patients will develop metastatic prostate cancer (mPC) and h
Autor:
James L. Gulley, Charalampos S. Floudas, Lisa M. Cordes, Fatima Karzai, Jeffrey Schlom, Elizabeth Lamping, Julius Strauss, Jason M. Redman, Ravi A. Madan, Deneise C Francis, Michell Manu, Caroline Jochems, Renee N. Donahue, Scott M. Norberg, Marijo Bilusic, Jenn Marte, Frank K. Bedu-Addo, Christian S. Hinrichs, Houssein Abdul Sater, Lauren Virginia Wood
Publikováno v:
Journal of Clinical Oncology. 39:2501-2501
2501 Background: There are more than 630,000 cases of HPV associated malignancies including cervical, oropharyngeal and anal cancer worldwide annually. HPV 16 is responsible for the majority of these cases. About 15-20% of HPV associated malignancies
Autor:
Jason M. Redman, Julius Strauss, Jennifer L. Marte, J. Schlom, H. Abdul-Sater, Marijo Bilusic, N. Williams, Michell Manu, Fatima Karzai, Amy Hankin, Charalampos S. Floudas, Ravi A. Madan, James L. Gulley, Lisa M. Cordes, William L. Dahut, Seth M. Steinberg, Margaret E. Gatti-Mays
Publikováno v:
Annals of Oncology. 31:S511
Autor:
Christopher R. Heery, Fatima Karzai, Michell Manu, Marijo Bilusic, Jennifer L. Marte, Yo-Ting Tsai, Jeffrey Schlom, Renee N. Donahue, Ravi A. Madan, Margaret E. Gatti-Mays, Julius Strauss, Lisa M. Cordes, Houssein Abdul‐Sater, Claudia Palena, James L. Gulley, Julie Collins
Publikováno v:
Oncologist
Lessons Learned Modified vaccinia Ankara-Bavarian Nordic (MVA-BN)-Brachyury followed by fowlpox virus-BN-Brachyury was well tolerated upon administration to patients with advanced cancer. Sixty-three percent of patients developed CD4+ and/or CD8+ T-c
Autor:
Margaret Elena Gatti-Mays, Elizabeth Lamping, Julius Strauss, Jennifer L. Marte, James L. Gulley, Jason M. Redman, Jeffrey Schlom, Ravi A. Madan, Lisa M. Cordes, Andrea Burmeister, Laureen S. Ojalvo, Michell Manu, Christoph Helwig
Publikováno v:
Journal of Clinical Oncology. 36:3007-3007
3007Background: Therapies targeting PD-1/L1 have produced response rates of 15-20% in patients (pts) with HPV associated cancers (HAC) including cervical (cerv), anal or head and neck squamous cell...
Autor:
Betsy Morrow, Regan M. Memmott, Stephen M. Hewitt, Douglas H. Weinstein, Michell Manu, Phillip A. Dennis, Gideon M. Blumenthal, Marc S. Ballas, Stephen A. Wank, Jennifer Morris, Roopa Dechowdhury, Thomas J. Hornyak, Takefumi Komiya, Suzanne Fioravanti
Publikováno v:
Journal of Clinical Oncology. 31:2532-2532
2532 Background: CS is characterized by germline PTEN mutations. Because tumors from CS patients show increased activation of the PI3K/Akt/mTOR pathway, mTOR inhibitor such as S might have activity in such patients. Methods: Eligibility: subjects wit
Autor:
Michell Manu, Ariel Lopez-Chavez, L. A. Doyle, Sean Khozin, Corrine Keen, Arun Rajan, Christina Brzezniak, Mark Raffeld, Giuseppe Giaccone, Corey A. Carter, Anish Thomas
Publikováno v:
Annals of Oncology. 24:i7
Autor:
Arlene Berman, Giuseppe Giaccone, David S. Schrump, Michell Manu, Eva Szabo, Arun Rajan, Udayan Guha, Corey A. Carter, Richard Piekarz, Anish Thomas, Sean Khozin, Tricia F. Kunst
Publikováno v:
Journal of Clinical Oncology. 30:7103-7103
7103 Background: Belinostat is a hydroxamic acid histone deacetylase (HDAC) pan-inhibitor with single agent activity in thymic malignancies. PAC has activity against thymic cancers. Synergy between Bel and several chemotherapeutic agents, including P